Last Price
46.90
Today's Change
+3.59 (8.28%)
Day's Change
46.20 - 49.83
Trading Volume
1,519,339
Exchange: New York Stock Exchange New York Stock Exchange
Currency: USD USD
Sector: Industrials - Industrials Industrials - Industrials
CEO: Mr. Matthew L. Trerotola Mr. Matthew L. Trerotola
Full Time Employees: 6,550 6,550
IPO Date: 2008-05-08 2008-05-08
CIK: 0001420800 0001420800
ISIN: US1940145022 US1940145022
CUSIP: 194014502 194014502
Beta: 2.00 2.00
Last Dividend: 0.00 0.00
Dcf Diff: 54.38 54.38
Dcf: -7.80 -7.80
Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports related injuries. It offers rigid and soft orthopedic bracings, hot and cold therapy products, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators used for pain management, and physical therapy products; and a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger. Enovis Corporation sells its products through independent distributors, such as healthcare professionals, consumer retail stores, and pharmacies; and directly under the DJO brand. The company was formerly known as Colfax Corporation. Enovis Corporation is headquartered in Wilmington, Delaware.